Abstract: The present invention relates to compounds containing a cyclobutanone group of the formula I where the various parameters are as defined in the text, and to liquid-crystal media which comprise these compounds, and to their use in electro-optical displays, in particular in PA LCDs.

Abstract: Helper dependent adenoviral vectors encoding erythropoietin (epo) provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration to patients with disorders such as anaemia of Chronic Renal Failure (CFR), anaemias due to beta-thalassaemia, and sickle cell anaemia (SCA).

Abstract: A class of phenylsulphonyl derivatives wherein the sulphonyl moiety is also attached to an N-arylalkyl-substituted azetidine, pyrrolidine or piperidine ring are selective antagonists of the human 5-HT2A receptor and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of adverse conditions of the central nervous system, including schizophrenia and depression.

Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds having positive dielectric aniostropy, characterized in that it comprises one or more compounds of the general formula I 1

Abstract: The invention relates to a non-dusting homogeneous pigment preparation notable in that it comprises at least 40% by weight of one or more effect pigments, from 0.5 to 50% by weight of water and/or an organic solvent or solvent mixture and from 0.5 to 59.5% by weight of a styrene-modified maleate resin having an acid number >90 mg KOH/g, and to its use in particular to produce dry preparations.

Abstract: Substituted heterocycles of the general structural formula: are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis, and calcium channel blockers useful in the treatment of cardiovascular conditions such as angina, hypertension or ischemia.

Abstract: Novel ethanes substituted with i) a phenyl, ii) a thiazole, and iii) a pyridyl moiety are PDE4 inhibitors.

Abstract: Cells and non-human transgenic animals have been engineered to be deficient in the gene encoding the melcanocortin-3 receptor protein (MC-3R). MC-3R deficient transgenic animals have increased fatmass and reduced lean body mass, showing that the MC-3R protein is involved in the regulation of body fat and muscle mass. These MC-3R deficient transgenic animals can be used to select for and test potential modulators of MC-3R. This data allows for methods of screening for MC-3R modulators which effect body weight and associated methods of treating various disorders associated with inappropriate regulation of body weight. The disclosure also relates to a MC-3R/MC-4R double knockout mouse which can be used to select for and test potential modulators (e.g., agonists or antagonists) of MC-3R and/or MC-4R. It is shown that MC-3R serves a non-redundant role, when compared to MC-4R, in the regulation of energy homeostasis.

Abstract: A carbon-based, adsorption powder containing an effective amount of cupric chloride suitable for removing mercury from a high temperature, high moisture gas stream, wherein the effective amount of cupric chloride ranges from about 1 to about 45 wt percent. Additional additives, such as potassium permanganate, calcium hydroxide, potassium iodide and sulfur, may be added to the powder to enhance the removal of mercury from the gas stream.

Abstract: A liquid-crystal medium comprising a) at least one compound of the formula I and b) at least one compound of the formula II wherein R11, R12, R21, R22, A1, A21, Z21, Z22, L21, L22 and I are as defined herein are suitable for use in ECB, VAN, IPS, GH and ASM-PA LCD displays.

Abstract: Compounds of general structural formula I are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.

Abstract: The present invention relates to compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses. The present invention further relates to compositions and methods for alleviating pain associated with skeletal injuries in horses and to treating skeletal injuries in horses.

Abstract: The invention relates to a process for preparing a support material having an increased number of reactive groups and to a process for preparing coreactive surfaces that may have catalytic or cocatalytic properties.

Abstract: The instant invention describes a method for crystallizing (−)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one from a solvent and anti-solvent system and producing the crystalline product. The desired final crystal form, Form I, can be produced when using methanol or ethanol. Form II is isolated from 2-propanol and can be converted to the desired crystal form at low drying temperatures, such as between about a temperature of 40° C. and 50° C.

Abstract: The invention relates to a liquid-crystalline medium comprising one or more compounds of the general formula (I) 1

Abstract: The invention relates to a liquid-crystalline medium comprising at least one compound of the formula I 1

Abstract: Disclosed is a tetracyclic compound of the formula I in which R1, R2 are each, independently of one another, an alkyl or alkenyl radical having up to 15 carbon atoms which is unsubstituted, monosubstituted by CN or CF3, or monosubstituted by halogen. One or more CH2 groups in these radicals may also, in each case independently of one another be replaced by —O—, —S—, —CO—, —CO—O—, —O—CO— or —O—CO—O— such that the O atoms are not linked directly to one another. Z is —OCF2—, —CF2O— or a single bond. L1, L2, L3, and L4 are each, independently of one another, H or F. m is 1 or 2. Similar compounds, as well as liquid-crystalline media having these compounds, are also disclosed.

Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, characterized in that it comprises one or more compounds of the general formula I: and simultaneously one or more compounds of the formula IIA: and/or one or more compounds of the formula IIB: in which R, R′, R″, R′″, L and Y are as defined in claim 1.

Abstract: The invention relates to a liquid-crystalline medium which is characterized in that it comprises one or more compounds of the formula A 1

Abstract: Described are dialkyne compounds of the formula I in which n, m, R1, R2, X1, X2, X3, X4, Z1, Z2, A1, A2, Q, Y1 and Y2 are as defined herein and the use of such compounds in liquid-crystal media.